Correlation of age and OCT features with efficacy of anti-VEGF agents for macular edema secondary to central retinal vein occlusion

AIM: To explore the correlation between age, OCT characteristics and the efficacy of anti-vascular endothelial growth factor(VEGF)drugs in the treatment of macular edema secondary to central retinal vein occlusion(CRVO).METHODS: Retrospective case-control study. From July 2017 to July 2019,47 eyes o...

Full description

Bibliographic Details
Main Authors: Yu-Meng Deng, Yan-Ping Song, Zhen Huang, Ya Ye, Ming Yan, Xiao-Li Huang
Format: Article
Language:English
Published: Press of International Journal of Ophthalmology (IJO PRESS) 2021-06-01
Series:Guoji Yanke Zazhi
Subjects:
Online Access:http://ies.ijo.cn/cn_publish/2021/6/202106025.pdf
_version_ 1818361608870559744
author Yu-Meng Deng
Yan-Ping Song
Zhen Huang
Ya Ye
Ming Yan
Xiao-Li Huang
author_facet Yu-Meng Deng
Yan-Ping Song
Zhen Huang
Ya Ye
Ming Yan
Xiao-Li Huang
author_sort Yu-Meng Deng
collection DOAJ
description AIM: To explore the correlation between age, OCT characteristics and the efficacy of anti-vascular endothelial growth factor(VEGF)drugs in the treatment of macular edema secondary to central retinal vein occlusion(CRVO).METHODS: Retrospective case-control study. From July 2017 to July 2019,47 eyes of 47 patients with CRVO were included and divided into group A(elderly group, age>50y, n=27)and group B(young and middle-aged group, age≤50y, n=20). All patients were received anti-VEGF therapy(3+PRN)and followed up for at least 12mo. The best corrected visual acuity(BCVA), the number of hyper-reflective dots(HRD), the average retinal thickness(ART)and central retinal thickness(CRT)were observed before and after treatment. The number of injections, the recovery rate of outer membrane(ELM)and ellipsoidal zone(EZ)were compared between the two groups, and the related indexes affecting visual prognosis were analyzed. RESULTS: After anti-VEGF treatment, BCVA was improved, the number of HRD decreased, CRT and ART thinned in both groups. During the follow up of 12mo after treatment, the frequency of injection of anti-VEGF drugs in the elderly group was higher than that in the young and middle-aged group(8.4±2.1 times vs 7.3±1.7 times, P=0.047), but there was no difference in the recovery rates of ELM and EZ between the two groups. BCVA in the elderly group was correlated with the age, HRD, ELM and EZ(all P<0.05). BCVA was correlated with age, ART, HRD, ELM and EZ in young and middle-aged patients(all P<0.05). CONCLUSION: Intravitreal injection of anti-VEGF drugs can effectively treat macular edema secondary to CRVO and the prognosis of young and middle-aged patients is better than that of elderly patients. Age and OCT indexes such as HRD, ELM and EZ are related to visual prognosis.
first_indexed 2024-12-13T21:19:24Z
format Article
id doaj.art-09d683d7ddc24d4bb6ab30910639ce7f
institution Directory Open Access Journal
issn 1672-5123
language English
last_indexed 2024-12-13T21:19:24Z
publishDate 2021-06-01
publisher Press of International Journal of Ophthalmology (IJO PRESS)
record_format Article
series Guoji Yanke Zazhi
spelling doaj.art-09d683d7ddc24d4bb6ab30910639ce7f2022-12-21T23:31:10ZengPress of International Journal of Ophthalmology (IJO PRESS)Guoji Yanke Zazhi1672-51232021-06-012161062106710.3980/j.issn.1672-5123.2021.6.25202106025Correlation of age and OCT features with efficacy of anti-VEGF agents for macular edema secondary to central retinal vein occlusionYu-Meng Deng0Yan-Ping Song1Zhen Huang2Ya Ye3Ming Yan4Xiao-Li Huang5Nanchang University School of Ophthalmology & Optometry, Nanchang 330000, Jiangxi Province, China; Department of Ophthalmology, Central Theater Command Hospital of People's Liberation Army, Wuhan 430070, Hubei Province, ChinaNanchang University School of Ophthalmology & Optometry, Nanchang 330000, Jiangxi Province, China; Department of Ophthalmology, Central Theater Command Hospital of People's Liberation Army, Wuhan 430070, Hubei Province, ChinaDepartment of Ophthalmology, Central Theater Command Hospital of People's Liberation Army, Wuhan 430070, Hubei Province, ChinaDepartment of Ophthalmology, Central Theater Command Hospital of People's Liberation Army, Wuhan 430070, Hubei Province, ChinaDepartment of Ophthalmology, Central Theater Command Hospital of People's Liberation Army, Wuhan 430070, Hubei Province, ChinaDepartment of Ophthalmology, Central Theater Command Hospital of People's Liberation Army, Wuhan 430070, Hubei Province, ChinaAIM: To explore the correlation between age, OCT characteristics and the efficacy of anti-vascular endothelial growth factor(VEGF)drugs in the treatment of macular edema secondary to central retinal vein occlusion(CRVO).METHODS: Retrospective case-control study. From July 2017 to July 2019,47 eyes of 47 patients with CRVO were included and divided into group A(elderly group, age>50y, n=27)and group B(young and middle-aged group, age≤50y, n=20). All patients were received anti-VEGF therapy(3+PRN)and followed up for at least 12mo. The best corrected visual acuity(BCVA), the number of hyper-reflective dots(HRD), the average retinal thickness(ART)and central retinal thickness(CRT)were observed before and after treatment. The number of injections, the recovery rate of outer membrane(ELM)and ellipsoidal zone(EZ)were compared between the two groups, and the related indexes affecting visual prognosis were analyzed. RESULTS: After anti-VEGF treatment, BCVA was improved, the number of HRD decreased, CRT and ART thinned in both groups. During the follow up of 12mo after treatment, the frequency of injection of anti-VEGF drugs in the elderly group was higher than that in the young and middle-aged group(8.4±2.1 times vs 7.3±1.7 times, P=0.047), but there was no difference in the recovery rates of ELM and EZ between the two groups. BCVA in the elderly group was correlated with the age, HRD, ELM and EZ(all P<0.05). BCVA was correlated with age, ART, HRD, ELM and EZ in young and middle-aged patients(all P<0.05). CONCLUSION: Intravitreal injection of anti-VEGF drugs can effectively treat macular edema secondary to CRVO and the prognosis of young and middle-aged patients is better than that of elderly patients. Age and OCT indexes such as HRD, ELM and EZ are related to visual prognosis.http://ies.ijo.cn/cn_publish/2021/6/202106025.pdfvascular endothelial growth factorcentral retinal vein occlusionintravitreal injectioninflammatory factoroptical coherence tomography
spellingShingle Yu-Meng Deng
Yan-Ping Song
Zhen Huang
Ya Ye
Ming Yan
Xiao-Li Huang
Correlation of age and OCT features with efficacy of anti-VEGF agents for macular edema secondary to central retinal vein occlusion
Guoji Yanke Zazhi
vascular endothelial growth factor
central retinal vein occlusion
intravitreal injection
inflammatory factor
optical coherence tomography
title Correlation of age and OCT features with efficacy of anti-VEGF agents for macular edema secondary to central retinal vein occlusion
title_full Correlation of age and OCT features with efficacy of anti-VEGF agents for macular edema secondary to central retinal vein occlusion
title_fullStr Correlation of age and OCT features with efficacy of anti-VEGF agents for macular edema secondary to central retinal vein occlusion
title_full_unstemmed Correlation of age and OCT features with efficacy of anti-VEGF agents for macular edema secondary to central retinal vein occlusion
title_short Correlation of age and OCT features with efficacy of anti-VEGF agents for macular edema secondary to central retinal vein occlusion
title_sort correlation of age and oct features with efficacy of anti vegf agents for macular edema secondary to central retinal vein occlusion
topic vascular endothelial growth factor
central retinal vein occlusion
intravitreal injection
inflammatory factor
optical coherence tomography
url http://ies.ijo.cn/cn_publish/2021/6/202106025.pdf
work_keys_str_mv AT yumengdeng correlationofageandoctfeatureswithefficacyofantivegfagentsformacularedemasecondarytocentralretinalveinocclusion
AT yanpingsong correlationofageandoctfeatureswithefficacyofantivegfagentsformacularedemasecondarytocentralretinalveinocclusion
AT zhenhuang correlationofageandoctfeatureswithefficacyofantivegfagentsformacularedemasecondarytocentralretinalveinocclusion
AT yaye correlationofageandoctfeatureswithefficacyofantivegfagentsformacularedemasecondarytocentralretinalveinocclusion
AT mingyan correlationofageandoctfeatureswithefficacyofantivegfagentsformacularedemasecondarytocentralretinalveinocclusion
AT xiaolihuang correlationofageandoctfeatureswithefficacyofantivegfagentsformacularedemasecondarytocentralretinalveinocclusion